Go Pro

MYCELX Technologies (MYX) Competitors

MYCELX Technologies logo
GBX 56 +1.50 (+2.75%)
As of 06:41 AM Eastern

MYX vs. CTG, GRA, WYG, INCE, and SNX

Should you buy MYCELX Technologies stock or one of its competitors? MYCELX Technologies's main competitors and comparable companies include Christie Group (CTG), Grafenia (GRA), WYG (WYG), The Ince Group (INCE), and Synectics (SNX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "commercial services & supplies" industry.

How does MYCELX Technologies compare to Christie Group?

MYCELX Technologies (LON:MYX) and Christie Group (LON:CTG) are both small-cap industrials companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, media sentiment, risk, analyst recommendations, institutional ownership, profitability, valuation and earnings.

MYCELX Technologies has a beta of 1.255, suggesting that its stock price is 26% more volatile than the broader market. Comparatively, Christie Group has a beta of 0.67, suggesting that its stock price is 33% less volatile than the broader market.

MYCELX Technologies has a net margin of 2.84% compared to Christie Group's net margin of -4.87%. MYCELX Technologies' return on equity of 7.39% beat Christie Group's return on equity.

Company Net Margins Return on Equity Return on Assets
MYCELX Technologies2.84% 7.39% -24.82%
Christie Group -4.87%-80.44%0.37%

Christie Group has higher revenue and earnings than MYCELX Technologies. Christie Group is trading at a lower price-to-earnings ratio than MYCELX Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MYCELX Technologies£11.74M1.16-£4.52M£1.0056.00
Christie Group£70.60M0.69-£3.31M£5.0637.55

18.1% of MYCELX Technologies shares are owned by institutional investors. Comparatively, 0.2% of Christie Group shares are owned by institutional investors. 30.4% of MYCELX Technologies shares are owned by company insiders. Comparatively, 61.4% of Christie Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Christie Group had 1 more articles in the media than MYCELX Technologies. MarketBeat recorded 1 mentions for Christie Group and 0 mentions for MYCELX Technologies. MYCELX Technologies' average media sentiment score of 0.00 equaled Christie Group'saverage media sentiment score.

Company Overall Sentiment
MYCELX Technologies Neutral
Christie Group Neutral

Summary

MYCELX Technologies and Christie Group tied by winning 6 of the 12 factors compared between the two stocks.

How does MYCELX Technologies compare to Grafenia?

MYCELX Technologies (LON:MYX) and Grafenia (LON:GRA) are both small-cap industrials companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, media sentiment, profitability, institutional ownership, valuation and earnings.

MYCELX Technologies has a net margin of 2.84% compared to Grafenia's net margin of -11.78%. MYCELX Technologies' return on equity of 7.39% beat Grafenia's return on equity.

Company Net Margins Return on Equity Return on Assets
MYCELX Technologies2.84% 7.39% -24.82%
Grafenia -11.78%-82.44%-4.07%

18.1% of MYCELX Technologies shares are held by institutional investors. Comparatively, 43.6% of Grafenia shares are held by institutional investors. 30.4% of MYCELX Technologies shares are held by insiders. Comparatively, 44.9% of Grafenia shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

MYCELX Technologies has a beta of 1.255, suggesting that its stock price is 26% more volatile than the broader market. Comparatively, Grafenia has a beta of 0.33, suggesting that its stock price is 67% less volatile than the broader market.

Grafenia has lower revenue, but higher earnings than MYCELX Technologies. Grafenia is trading at a lower price-to-earnings ratio than MYCELX Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MYCELX Technologies£11.74M1.16-£4.52M£1.0056.00
Grafenia£11.68M0.00-£1.41M-£0.01N/A

In the previous week, MYCELX Technologies' average media sentiment score of 0.00 equaled Grafenia'saverage media sentiment score.

Company Overall Sentiment
MYCELX Technologies Neutral
Grafenia Neutral

Summary

MYCELX Technologies beats Grafenia on 6 of the 10 factors compared between the two stocks.

How does MYCELX Technologies compare to WYG?

MYCELX Technologies (LON:MYX) and WYG (LON:WYG) are both small-cap industrials companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, dividends, analyst recommendations, profitability, valuation, risk and media sentiment.

In the previous week, MYCELX Technologies' average media sentiment score of 0.00 equaled WYG'saverage media sentiment score.

Company Overall Sentiment
MYCELX Technologies Neutral
WYG Neutral

18.1% of MYCELX Technologies shares are held by institutional investors. 30.4% of MYCELX Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

WYG has higher revenue and earnings than MYCELX Technologies. WYG is trading at a lower price-to-earnings ratio than MYCELX Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MYCELX Technologies£11.74M1.16-£4.52M£1.0056.00
WYG£154.43M0.00N/A-£6.70N/A

MYCELX Technologies has a net margin of 2.84% compared to WYG's net margin of 0.00%. MYCELX Technologies' return on equity of 7.39% beat WYG's return on equity.

Company Net Margins Return on Equity Return on Assets
MYCELX Technologies2.84% 7.39% -24.82%
WYG N/A N/A N/A

Summary

MYCELX Technologies beats WYG on 6 of the 8 factors compared between the two stocks.

How does MYCELX Technologies compare to The Ince Group?

MYCELX Technologies (LON:MYX) and The Ince Group (LON:INCE) are both small-cap industrials companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, media sentiment, risk, institutional ownership, dividends, profitability, valuation and analyst recommendations.

MYCELX Technologies has a net margin of 2.84% compared to The Ince Group's net margin of 0.60%. MYCELX Technologies' return on equity of 7.39% beat The Ince Group's return on equity.

Company Net Margins Return on Equity Return on Assets
MYCELX Technologies2.84% 7.39% -24.82%
The Ince Group 0.60%3.28%3.94%

MYCELX Technologies has a beta of 1.255, meaning that its stock price is 26% more volatile than the broader market. Comparatively, The Ince Group has a beta of 1.79, meaning that its stock price is 79% more volatile than the broader market.

18.1% of MYCELX Technologies shares are held by institutional investors. Comparatively, 15.3% of The Ince Group shares are held by institutional investors. 30.4% of MYCELX Technologies shares are held by insiders. Comparatively, 9.9% of The Ince Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

The Ince Group has higher revenue and earnings than MYCELX Technologies. The Ince Group is trading at a lower price-to-earnings ratio than MYCELX Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MYCELX Technologies£11.74M1.16-£4.52M£1.0056.00
The Ince Group£102.47M0.37£1.37M£0.8711.88

In the previous week, MYCELX Technologies' average media sentiment score of 0.00 equaled The Ince Group'saverage media sentiment score.

Company Overall Sentiment
MYCELX Technologies Neutral
The Ince Group Neutral

Summary

MYCELX Technologies beats The Ince Group on 7 of the 11 factors compared between the two stocks.

How does MYCELX Technologies compare to Synectics?

Synectics (LON:SNX) and MYCELX Technologies (LON:MYX) are both small-cap industrials companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, earnings, analyst recommendations, media sentiment, institutional ownership, dividends, valuation and risk.

In the previous week, Synectics' average media sentiment score of 0.00 equaled MYCELX Technologies'average media sentiment score.

Company Overall Sentiment
Synectics Neutral
MYCELX Technologies Neutral

Synectics has higher revenue and earnings than MYCELX Technologies. Synectics is trading at a lower price-to-earnings ratio than MYCELX Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Synectics£54.85M0.56£2.93M£4.4040.91
MYCELX Technologies£11.74M1.16-£4.52M£1.0056.00

8.9% of Synectics shares are owned by institutional investors. Comparatively, 18.1% of MYCELX Technologies shares are owned by institutional investors. 22.8% of Synectics shares are owned by company insiders. Comparatively, 30.4% of MYCELX Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

MYCELX Technologies has a net margin of 2.84% compared to Synectics' net margin of 1.29%. MYCELX Technologies' return on equity of 7.39% beat Synectics' return on equity.

Company Net Margins Return on Equity Return on Assets
Synectics1.29% 1.64% 5.02%
MYCELX Technologies 2.84%7.39%-24.82%

Synectics has a beta of 0.656, indicating that its stock price is 34% less volatile than the broader market. Comparatively, MYCELX Technologies has a beta of 1.255, indicating that its stock price is 26% more volatile than the broader market.

Summary

MYCELX Technologies beats Synectics on 7 of the 11 factors compared between the two stocks.

Get MYCELX Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for MYX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MYX vs. The Competition

MetricMYCELX TechnologiesCommercial Services & Supplies IndustryIndustrials SectorLON Exchange
Market Cap£13.64M£4.20B£10.20B£2.87B
Dividend YieldN/A5.05%97.17%6.26%
P/E Ratio56.0027.2125.46366.92
Price / Sales1.16963.72307.6090,001.90
Price / Cash1.9621.8123.7127.89
Price / Book2.194.134.786.33
Net Income-£4.52M£145.77M£612.22M£5.89B
7 Day Performance11.87%-1.60%-0.11%-0.75%
1 Month Performance27.27%-2.17%-4.07%-0.68%
1 Year Performance107.82%2.91%5.72%19.29%

MYCELX Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MYX
MYCELX Technologies
N/AGBX 56
+2.8%
N/A+107.4%£13.64M£11.74M56.00N/A
CTG
Christie Group
N/AGBX 180
+4.3%
N/A+64.9%£46.13M£70.60M35.573,450
GRA
Grafenia
N/AN/AN/AN/A£41.93M£11.68MN/A92
WYG
WYG
N/AN/AN/AN/A£39.97M£154.43MN/A1,612
INCE
The Ince Group
N/AGBX 10.33
+0.1%
N/AN/A£37.92M£102.47M11.88700

Related Companies and Tools


This page (LON:MYX) was last updated on 9/15/2026 by MarketBeat.com Staff.
From Our Partners